Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 50.00
-3.10 (-5.84%)
At close: Mar 6, 2026
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 25.9 billion as of March 6, 2026.
Market Cap
25.90B
Enterprise Value
25.78B
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.00
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has increased from 13.62B to 25.90B, an increase of 90.11%. That is a compound annual growth rate of 421.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 25.90B | -29.08% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 31.41B |
| Simcere Pharmaceutical Group | 29.75B |
| China Resources Pharmaceutical Group | 27.64B |
| Grand Pharmaceutical Group | 25.18B |
| The United Laboratories International Holdings | 25.06B |
| OneRobotics (Shenzhen) | 24.40B |
| Sunshine Lake Pharma | 23.77B |
| Ab&B Bio-Tech CO., LTD. JS | 20.52B |